Stamaril Indications/Uses

STAMARIL is indicated for active immunization against yellow fever in persons: travelling to, passing through or living in an area where there is a persisting or periodical risk of yellow fever transmission; travelling to any country that requires an International Certificate of Vaccination for entry (which may or may not depend on the previous itinerary); handling potentially infectious materials (e.g., laboratory personnel).
See Dosage & Administration, Contraindications and Precautions regarding the minimum age for vaccination of children under special circumstances and guidance for vaccination of other specific patient populations.
See the regular updates related to obligations and recommendations for yellow fever vaccination on the dedicated site of the World Health Organisation (WHO) or on the official sites of local health authorities.
In order to comply with vaccine regulations and to be officially recognised, yellow fever vaccines must be administered by a qualified and trained health professional in an approved WHO vaccination centre and registered on an International Certificate of Vaccination. The validity period of this Certificate is established according to International Health Regulations (IHR) recommendations, and starts 10 days after primary vaccination and immediately after re-vaccination (See Dosage & Administration).